Senior insider sale
Chief Executive Officer at KUVATRIS THERAPEUTICS, INC. — senior position signals high conviction
$20.6K
44.13K shares
What this filing means
WEISMAN HOWARD J. plans to sell 44.13K shares of KUVATRIS THERAPEUTICS, INC. valued at approximately $20.6K. Form 144 is a notice of intent to sell restricted or control securities — not a mandatory transaction. This filing provides advance warning of potential selling pressure.
Filed: 8/30/2023ACC: 0001973379-23-000141
DirectorOfficer· Chief Executive Officer
Since Aug 2022
44.13K
Shares to sell
$20.6K
Approx. market value
66.67K
Acquired (3 months)
1
Planned
Securities Acquired — Last 3 Months1
Restricted Stock Vesting
Services Rendered
8/28/2023
66.67KTotal acquired66.67K
| Acquisition Date | Type | Amount Acquired | Gift |
|---|---|---|---|
8/28/2023 | Restricted Stock Vesting Services Rendered | 66.67K | — |
| Total | 66.67K | ||
Planned & Completed Dispositions1
NASDAQPlanned
Units to sell
44.13K
Market value
$20.6K
8/28/2023
Total
Units
44.13K
Value
$20.6K
| Date | Units to Sell | Approx. Market Value | Exchange | Status |
|---|---|---|---|---|
8/28/2023 | 44.13K | $20.6K | NASDAQ | Planned |
| Total | 44.13K | $20.6K | ||